POST Online Media Lite Edition


Outbreak of pneumococcal disease in shipyards in Vestnes in Norway

Christian Fernsby |
Since January 2019, nine workers in the shipbuilding industry in Møre og Romsdal have been hospitalised with severe pneumococcal disease.

Article continues below

These infections were caused by the same bacterial strain.

The patients have now been successfully treated and discharged from hospital.

In addition, six unconfirmed cases that may be related to the outbreak have been reported.

Pneumococcal bacteria are commonly found in the nose and throat of healthy individuals.

The bacteria generally cause mild infections, such as ear and sinus infections.

However, in some cases, the bacteria can cause serious illness, such as pneumonia, meningitis or sepsis.

Welders and laboratory personnel have an increased risk of developing pneumococcal disease.

Working environments where many people work together in confined spaces or with poor ventilation can increase the risk of infection and disease.

It is also possible that the bacterial strain detected in this outbreak is more easily transmitted or more likely to cause disease than other pneumococcal bacteria.

The Norwegian Institute of Public Health is assisting the Municipal Health Services with advice on infection control and vaccination.

The Municipal Health Services and Norwegian Institute of Public Health are also co-operating with the Norwegian Labour Inspection Authority.

In response to the outbreak, the pneumococcal vaccine is being offered to affected workers with resources provided by the employer.

Local health authorities and the shipyard management have initiated information campaigns and are preparing to offer the vaccine to employees.

The Norwegian Institute of Public Health has developed information letters about the outbreak and pneumococcal vaccine in Norwegian, English, Polish and Italian.

These have been provided to the shipyard management and the Municipal Health Service to support the outbreak response.

The Norwegian Institute of Public Health is currently processing the request for the pneumococcal vaccine, which was received on 3 April 2019.

There is no indication that the general population, or people who are not exposed through the working environment, are at increased risk of pneumococcal disease.

For these groups, general advice on pneumococcal vaccination applies.

What to read next

Britain unveils new national warship building strategy
Expanded Marine rotational force deploys to Norway
Norway turns toilets into tourist attraction